Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NIH Could Get Royalties, Not Input On Pricing, From R&D Investments, Collins Says

Executive Summary

Federal funding for research and development of drugs can garner royalties for the U.S. Treasury but does not provide leverage to affect pricing decisions, National Institutes of Health Director Francis Collins told a Senate appropriations subcommittee May 11.

You may also be interested in...

Collins Promises To Send NCATS Funding Proposal To Congress Within Weeks

National Institutes of Health Director Francis Collins expects to send, "in the fairly near future," detailed plans to Congress for shifting existing translational research projects into a new National Center for Advancing Translational Research.

FDA Steps Into Makena Pricing Dispute In The Name Of "Access"

FDA is citing patient access as the reason behind its unusual decision to insert itself in the middle of a pricing debate involving KV Pharmaceuticals’ pre-term delivery drug Makena.

Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says

Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts